EQL Pharma Investor Relations

Anders Månsson

Board member

Education

BSc & MBA

Born

1967

Shareholding

10,000 shares

Independent

Yes

Assumed

Board member since 2018

Professional experience

With more than 30 years of experience in the pharmaceutical industry, Anders has held several leading positions in multinational pharmaceutical companies, both abroad and in Sweden. He is currently CEO of Phase Holographic Imaging AB, a Swedish biotechnology company active in Digital Holographic Microscopy and Cell Monitoring. He is also a board member of Immetric AB, a private seed capital company that works with investments in early-stage technology-based private companies.